Search

Perrigo Co PLC

Cerrado

SectorSanidad

10.46 -1.23

Resumen

Variación precio

24h

Actual

Mínimo

10.27

Máximo

10.64

Métricas clave

By Trading Economics

Ingresos

1B

-390M

Ventas

-140M

969M

BPA

0.43

Rentabilidad por dividendo

11.14

Margen de beneficios

-40.229

Empleados

8,100

EBITDA

962M

-284M

Recomendaciones

By TipRanks

Recomendaciones

Comprar

Estimación a 12 Meses

+60.53% upside

Dividendos

By Acuity

Rentabilidad por dividendo

Media del Sector

11.14%

2.24%

Próximas Ganancias

5 ago 2026

Fecha Próximo Dividendo

15 sept 2026

Próxima Fecha de Ex Dividendo

28 ago 2026

Estadísticas de Mercado

By TradingEconomics

Capitalización Mercado

-154M

1.4B

Apertura anterior

11.69

Cierre anterior

10.46

Perrigo Co PLC Gráfico

Resultados pasados no son un indicador fiable de resultados futuros.

Noticias Relacionadas

21 jul 2026, 17:16 UTC

Perrigo Company PLC shares are lower today, extending a trend of three consecutive sessions of declines. No specific news was identified to explain the movement.

20 jul 2026, 19:22 UTC

Perrigo Company PLC shares are lower today, influenced by a decline in the Pharmaceuticals sub-sector. This marks a break from recent higher daily closes.

Comparación entre iguales

Cambio de precio

Perrigo Co PLC previsión

Precio Objetivo

By TipRanks

60.53% repunte

Estimación a 12 Meses

Media 17 USD  60.53%

Máximo 17 USD

Mínimo 17 USD

De acuerdo con 2 analistas de Wall Street que ofrecen objetivos de precios a 12 meses para Perrigo Co PLC Dist en los últimos 3 meses.

Consenso

By TipRanks

Comprar

2 ratings

1

Comprar

1

Mantener

0

Vender

Finanzas

Gastos de venta y administración

Gastos operativos

Beneficio antes de impuestos

Ventas

Coste de ventas

Beneficio bruto de ventas

Gasto por intereses de deuda

EBITDA

Beneficio operativo

$

Acerca de Perrigo Co PLC

Perrigo Company plc provides over-the-counter health and wellness solutions to enhance individual well-being in the United States, Europe, and internationally. It operates through Consumer Self-Care Americas and Consumer Self-Care International segments. The company develops, manufactures, markets, and distributes self-care consumer products, such as upper respiratory products, including cough suppressants, expectorants, and sinus and allergy relief; nutrition products consisting of infant formulas and nutritional beverages; digestive health products, including antacids, anti-diarrheal, and anti-heartburn; pain and sleep-aids products comprising pain relievers and fever reducers; and oral care products, which include toothbrushes, toothbrush replacement heads, floss, flossers, whitening products, and toothbrush covers. It also offers healthy lifestyle products, such as smoking cessation, well-being, and weight management products; skin care products consisting of dermatological care, scar management, lice treatment, and other products for various skin conditions; women's health products comprising feminine hygiene and contraceptives; vitamins, minerals, and supplements; rare diseases business; and other miscellaneous self-care products. The company sells its products under the Compeed, Dr. Fresh, Firefly, Good Sense, Good Start, Mederma, Nasonex, Plackers, Prevacid24HR, REACH, Rembrandt, Steripod, Opill, Solpadeine, Coldrex, Physiomer, NiQuitin, ACO, ellaOne, Compeed Stops, XLS, Arterin, Davitamon, Apiserum, Abtei, and Nicorette brands. It also offers contract manufacturing services. The company sells its products through retail drug, supermarket, and mass merchandise chains; e-commerce stores; wholesalers; pharmacies; drug and grocery retailers; and para-pharmacies. The company was formerly known as Perrigo Company and changed its name to Perrigo Company plc in December 2013. Perrigo Company plc was founded in 1887 and is headquartered in Dublin, Ireland.